LHC Group (NASDAQ:LHCG) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a note issued to investors on Tuesday.

According to Zacks, “LHC Group is the preferred post-acute care partner for hospitals, physicians and families nationwide. From home health and hospice care to long-term acute care and community-based services, LHC delivers high-quality, cost-effective care that empowers patients to manage their health at home. More than 60 leading hospitals and health systems around the country have partnered with LHC Group to deliver patient-centered care in the home. More hospitals, physicians and families choose LHC Group, because our 13,000-plus employees in 26 states are united by a single, shared purpose: It’s all about helping people. “

LHCG has been the topic of several other research reports. Robert W. Baird reiterated a “hold” rating and issued a $69.00 price objective on shares of LHC Group in a report on Friday, November 10th. Royal Bank of Canada lifted their price objective on LHC Group from $70.00 to $81.00 and gave the stock an “outperform” rating in a report on Tuesday, November 7th. Oppenheimer lifted their price objective on LHC Group from $68.00 to $80.00 and gave the stock an “outperform” rating in a report on Tuesday, November 7th. Jefferies Group lifted their price objective on LHC Group from $68.00 to $83.00 and gave the stock a “buy” rating in a report on Tuesday, November 7th. They noted that the move was a valuation call. Finally, Craig Hallum reiterated a “buy” rating and issued a $80.00 price objective (up previously from $67.00) on shares of LHC Group in a report on Tuesday, November 7th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and nine have issued a buy rating to the stock. LHC Group currently has an average rating of “Buy” and an average target price of $77.10.

Shares of LHC Group (NASDAQ LHCG) opened at $61.26 on Tuesday. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.77 and a quick ratio of 1.77. LHC Group has a 12-month low of $44.04 and a 12-month high of $76.14. The stock has a market capitalization of $1,176.07, a price-to-earnings ratio of 26.41, a P/E/G ratio of 1.72 and a beta of 0.70.

LHC Group (NASDAQ:LHCG) last released its quarterly earnings results on Monday, November 6th. The health services provider reported $0.64 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.60 by $0.04. LHC Group had a return on equity of 9.52% and a net margin of 4.09%. The business had revenue of $272.90 million for the quarter, compared to the consensus estimate of $265.35 million. During the same quarter last year, the business posted $0.54 earnings per share. The company’s revenue for the quarter was up 18.2% on a year-over-year basis. analysts expect that LHC Group will post 2.4 EPS for the current fiscal year.

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Nine Chapters Capital Management LLC bought a new stake in shares of LHC Group in the third quarter worth about $255,000. BNP Paribas Arbitrage SA grew its stake in shares of LHC Group by 54.0% in the third quarter. BNP Paribas Arbitrage SA now owns 8,662 shares of the health services provider’s stock worth $614,000 after purchasing an additional 3,037 shares during the last quarter. Vident Investment Advisory LLC bought a new stake in shares of LHC Group in the third quarter worth about $2,448,000. Linscomb & Williams Inc. bought a new stake in LHC Group during the 2nd quarter valued at approximately $2,268,000. Finally, Bessemer Group Inc. boosted its position in LHC Group by 17.2% during the 3rd quarter. Bessemer Group Inc. now owns 20,400 shares of the health services provider’s stock valued at $1,447,000 after acquiring an additional 3,000 shares in the last quarter. 85.41% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY WARNING: This article was posted by American Banking News and is owned by of American Banking News. If you are reading this article on another site, it was illegally stolen and republished in violation of US and international copyright laws. The legal version of this article can be viewed at https://www.americanbankingnews.com/2018/01/09/lhc-group-lhcg-downgraded-to-sell-at-zacks-investment-research.html.

About LHC Group

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Get a free copy of the Zacks research report on LHC Group (LHCG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.